• Liver cancer: Humanitas expertise that revolutionized surgery
• Hepatocarcinoma and cholangiocarcinoma: new treatment for liver tumors
• Advanced hepatocarcinoma: positive results from the Cabozantinib study, in which Humanitas also took part
• EASL 2018: medicines for liver cirrhosis and risk of liver cancer, the encouraging results of an Italian study coordinated by Humanitas
• EASL 2018: The Role of the Medical Oncologist in the Multidisciplinary Management of Hepatic carcinoma, Dr. Rimassa’s Report
• Hepatocarcinoma: the results of the Humanitas study published in The Lancet Oncology
• An Award-Winning Feasibility Study Coordinated by Humanitas, on the Planning of Stereotactic Radiotherapy